Company intelligence / Profile preview

Ancon Technologies

London, England, United Kingdomzoominfo.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Ancon Technologies developed proprietary nanotechnology-based platforms for ultra-sensitive detection of disease biomarkers in exhaled breath. Their NBT and NMT technologies have been used to develop non-invasive diagnostic devices targeting early cancer detection and infectious diseases such as COVID‑19. The company has demonstrated proof-of-concept and participated in international innovation competitions but there are no published large-scale clinical trial results or regulatory approvals found. The company entered voluntary liquidation around mid‑2023.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: DeviceNanoparticle Biomarker TaggingNanotechnology Molecular Tagging
Industry: Metabolite Diagnostics

Partnerships

Participated in Envestors’ China programme; connections with Chinese strategic investors/government-backed tech transfer organizations

Beyond the preview

Go deeper on Ancon Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ancon Technologies.

Explore the full profile